Literature DB >> 25168455

Aceruloplasminemia.

Hiroaki Miyajima1.   

Abstract

Aceruloplasminemia is characterized by progressive neurodegeneration with brain iron accumulation due to the complete lack of ceruloplasmin ferroxidase activity caused by mutations in the ceruloplasmin gene. Redox-active iron accumulation was found to be more prominent in the astrocytes than in the neurons. The most characteristic findings were abnormal or deformed astrocytes and globular structures of astrocytes. The lack of ceruloplasmin may primarily damage astrocytes in the aceruloplasminemic brains as a result of lipid peroxidation due to massive iron deposition. In the normal brain, iron may be continuously recycled between astrocytes and neurons, with transferrin acting as a shuttle. The glycosylphosphatidylinositol (GPI)-linked ceruloplasmin on astrocytes functions as a ferroxidase, mediating the oxidation of ferrous iron transported from the cytosol by ferroportin and its subsequent transfer to transferrin. In cases with aceruloplasminemia, neurons take up the iron from alternative sources of non-transferrin-bound iron, because astrocytes without GPI-linked ceruloplasmin cannot transport iron to transferrin. The excess iron in astrocytes could result in oxidative damage to these cells, and the neuronal cell protection offered by astrocytes would thus be disrupted. Neuronal cell loss may result from iron starvation in the early stage and from iron-mediated oxidation in the late stage. Ceruloplasmin may therefore play an essential role in neuronal survival in the central nervous system.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  ceruloplasmin; ferroportin; ferroxidase; hepcidin; iron; iron metabolic cycle; neurodegeneration

Mesh:

Substances:

Year:  2014        PMID: 25168455     DOI: 10.1111/neup.12149

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  19 in total

1.  Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.

Authors:  H K Kim; C S Ki; Y J Kim; M S Lee
Journal:  Clin Neuroradiol       Date:  2017-03-03       Impact factor: 3.649

Review 2.  Contributions to magnetic susceptibility of brain tissue.

Authors:  Jeff H Duyn; John Schenck
Journal:  NMR Biomed       Date:  2016-05-30       Impact factor: 4.044

3.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

Review 4.  "Ferritin Out" a Cause of Acute Hepatitis.

Authors:  Diego Colom Steele; Amirkaveh Mojtahed; Von Samedi; Joseph Alcorn
Journal:  Dig Dis Sci       Date:  2015-08-05       Impact factor: 3.487

5.  Off-resonance saturation as an MRI method to quantify mineral- iron in the post-mortem brain.

Authors:  Lucia Bossoni; Ingrid Hegeman-Kleinn; Sjoerd G van Duinen; Marjolein Bulk; Lena H P Vroegindeweij; Janneke G Langendonk; Lydiane Hirschler; Andrew Webb; Louise van der Weerd
Journal:  Magn Reson Med       Date:  2021-10-15       Impact factor: 3.737

6.  Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.

Authors:  Alan Zanardi; Antonio Conti; Marco Cremonesi; Patrizia D'Adamo; Enrica Gilberti; Pietro Apostoli; Carlo Vittorio Cannistraci; Alberto Piperno; Samuel David; Massimo Alessio
Journal:  EMBO Mol Med       Date:  2018-01       Impact factor: 12.137

7.  The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia.

Authors:  Soichiro Nagata; Naoki Ikegaya; Shuhei Ogino; Shinichi Uchida; Mikiko Itaya; Aoi Momita; Shingo Shinozaki; Masaharu Ohura; Ken Kuriki; Satoshi Kono; Hiroaki Miyajima; Akira Hishida
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

Review 8.  Disorders of metal metabolism.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-12-18

9.  Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene.

Authors:  Ayako Yamamura; Yoshitaka Kikukawa; Kenji Tokunaga; Eiko Miyagawa; Shinya Endo; Hirosada Miyake; Hiroyuki Hata; Hiroaki Mitsuya; Kunihiro Yoshida; Masao Matsuoka
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

10.  Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.

Authors:  Maki Watanabe; Ken Ohyama; Masashi Suzuki; Yasunobu Nosaki; Takashi Hara; Katsushige Iwai; Satoshi Kono; Hiroaki Miyajima; Kenji Mokuno
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.